Dr. Nora Volkow, a distinguished neuroscientist, is an important contributor in the fields of addiction science and mental health research.
Born in Mexico City in 1956, Dr. Volkow demonstrated academic prowess from the start, attending the National University of Mexico’s Medical School, where she was awarded the prestigious Robins Award for being the best medical student of her generation. She attending New York University to further her expertise in psychiatry, earning a Laughlin Fellowship for being one of the ten most outstanding psychiatric residents in the United States.
Dr. Volkow’s innovative work in brain imaging has redefined our understanding of addiction. She has extensively studied the dopamine system, demonstrating how substance use alters brain function, particularly in areas tied to reward and self-control. She has also made key contributions to the neurobiology of obesity, ADHD, and aging. In 2003, she was appointed Director of the National Institute on Drug Abuse (NIDA), where she continues to lead groundbreaking efforts and studies on combatting substance abuse and its societal impact.
During her illustrious career, Dr. Volkow has authored nearly 1,000 peer-reviewed articles and over 100 book chapters and manuscripts, reflecting the depth and breadth of her influence. Her work has earned her numerous accolades, including the Nathan Davis Award for Outstanding Government Service and the International Prize from the French Institute of Health and Medical Research. Her efforts were further honored with the Carnegie Prize in Mind and Brain Sciences and induction into the CHADD Hall of Fame.
She has been celebrated by major publications, such as Time magazine, which named her one of the “Top 100 People Who Shape Our World,” and Newsweek, which listed her among “20 People to Watch.” Her role as a thought leader garnered her inclusion in Washingtonian magazine’s “100 Most Powerful Women” and Fortune’s “34 Leaders Who Are Changing Health Care.”
Dr. Volkow is an inspiring example not only for women, but for how scientific innovation can drive meaningful progress in public health.
*All information obtained from National Institute on Drug Abuse
Disclaimer: The views and opinions expressed in this interview are those of the interviewees and do not necessarily reflect the views or positions of Public Health Landscape or Valent BioSciences, LLC.